Search
Prestige Consumer Healthcare Inc
PBHAdd to Watchlist
45.260USD
+0.490+1.09%
Close 10-02 16:00（ET）
2.14BMarket Cap
11.52P/E TTM
After-hours 19:27 (ET)45.400USD+0.060+0.13%
After-hours 19:27 (ET)Prestige Consumer Healthcare Inc (PBH) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Prestige Consumer Healthcare Inc in the past month.
Buy
2 Strong Buy
2 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
67.250USD+50.21%
PBH Analyst Recommendation Trends
In the current month, PBH has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. PBH average Analyst price target in the last month is 67.250.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
6
6
6
6
6
6
PBH Analyst Rating for Peer Comparison
Updated: Oct 2, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Eli Lilly and Co
LLY
10
18
3
1
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, PBH EPS is projected to reach 1.069 in FY2027Q2, following reported EPS of 0.615 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
Forecast
1.14
1.39
0.88
1.07
1.24
Actual
0.98
1.14
0.61
--
--
Surprise
-14.77%
-18.24%
-30.30%
--
--
FAQs
What is Prestige Consumer Healthcare Inc's expected revenue for the next quarter?
Prestige Consumer Healthcare Inc's expected revenue is 329.13M.
What is Prestige Consumer Healthcare Inc's price target?
Analysts forecast that Prestige Consumer Healthcare Inc's price target is USD 67.25, with the highest forecast at USD 75.00 and the lowest forecast at USD 55.00.
How have Prestige Consumer Healthcare IncPBH's recent earnings per share performed?
The market expectation was USD 0.61, while Prestige Consumer Healthcare IncPBH's earnings per share (EPS) for the previous quarter was USD 1.14. EPS for the next quarter is expected at USD 1.07.
What is the analyst rating for Prestige Consumer Healthcare Inc?
Based on the ratings of Prestige Consumer Healthcare Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.